Clinical Trial Update: Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating Fasudil hydrochloride plus a PD-1 inhibitor in combination with androgen deprivation as neoadjuvant therapy for prostate c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Fasudil Hydrochloride (fasudil hydrochloride)
• PD-1 inhibitor

Snippet

Sponsor: baotai Liang | Conditions: Prostate CA | Phase 2, Phase 3 | Status: RECRUITING